CorMedix (CRMD) Cash from Investing Activities (QoQ) (2015 - 2025)
CorMedix (CRMD) Cash from Investing Activities (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CorMedix | 4.95 Mn | -150.26 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.13% |
| Sep 30, 2025 | -1,341.34% |
| Jun 30, 2025 | -10,274.59% |
| Mar 31, 2025 | 35.89% |
| Dec 31, 2024 | -104.81% |
| Sep 30, 2024 | 0.84% |
| Jun 30, 2024 | -29.92% |
| Mar 31, 2024 | 1,396.33% |
| Dec 31, 2023 | 201.86% |
| Sep 30, 2023 | 75.40% |
| Jun 30, 2023 | 83.76% |
| Mar 31, 2023 | -789,088.88% |
| Dec 31, 2022 | 98.37% |
| Sep 30, 2022 | -119.23% |
| Jun 30, 2022 | 114.20% |
| Mar 31, 2022 | 41.26% |
| Dec 31, 2021 | -460.73% |
| Sep 30, 2021 | -510.45% |
| Jun 30, 2021 | 60.41% |
| Mar 31, 2021 | 71.53% |